Warnings
Heroin (53.3%); Noscapine (37%); Acetylcodeine (4%); Paracetamol (2.4%); Caffeine (0.8%); 6-MAM (0.7%)
预期内容为 海洛因。 检测到 海洛因 53.3%, 诺斯卡品 37%, 乙酰可待因 4%, 扑热息痛 2.4%, 咖啡因 0.8%, 6-MAM 0.7%。 地点:Vitoria-Gasteiz, 西班牙。 日期:2026-01-01。 来源:ailaket.com。
Heroin (53.3%); Noscapine (37%); Acetylcodeine (4%); Paracetamol (2.4%); Caffeine (0.8%); 6-MAM (0.7%) 药丸 — Vitoria-Gasteiz, 西班牙 — 2026-01-01
- Detected
- Heroin 53.3%, Noscapine 37%, Acetylcodeine 4%, Paracetamol 2.4%, Caffeine 0.8%, 6-MAM 0.7%
- Expected
- Heroin
- Logo
- Unknown
- Color
- Unknown
- Location
- Vitoria-Gasteiz, Spain
- Date
- 2026-01-01
- Source
- ailaket.com
- Media
- No image
Detected Substances
- Heroin 53.3%
- Noscapine 37%
- Acetylcodeine 4%
- Paracetamol 2.4%
- Caffeine 0.8%
- 6-MAM 0.7%
Expected vs Detected
Heroin
Detected result: Heroin 53.3%, Noscapine 37%, Acetylcodeine 4%, Paracetamol 2.4%, Caffeine 0.8%, 6-MAM 0.7%
Sample Details
No additional sample descriptors available.
Testing Context
- Location: Vitoria-Gasteiz, 西班牙
- Date tested: 2026-01-01
- Source: ailaket.com
Harm Reduction
- Similar-looking pills can contain different substances or strengths.
- Use drug checking services when available.
- Start low and avoid assuming a logo identifies the contents.
SampleDNA Beta
3342 条相关警告 · 了解常见杂质的更多信息。
- Heroin53.3%
- Noscapine37%
- Acetylcodeine4%
- Paracetamol2.4%
- Caffeine0.8%
- 6-MAM0.7%
相关样本和组合
6-MAM + Acetylcodeine + Caffeine + Heroin + Noscapine + Paracetamol
2 份样本 · 当前结果
在相关药物检测结果中共同检测到。
6-MAM + Acetylcodeine + Caffeine + Heroin + Noscapine + Papaverine + Paracetamol
13 份样本
在相关药物检测结果中共同检测到。
6-MAM + Acetylcodeine + Caffeine + Heroin + Noscapine + Papaverine + Paracetamol + Unknown
7 份样本
在相关药物检测结果中共同检测到。
6-MAM + Acetylcodeine + Caffeine + Heroin + Medetomidine + Noscapine + Papaverine + Paracetamol
6 份样本
在相关药物检测结果中共同检测到。
6-MAM + Acetylcodeine + Caffeine + Heroin + Metonitazene + Noscapine + Papaverine + Paracetamol
4 份样本
在相关药物检测结果中共同检测到。
SampleDNA 探索器
Links
This static page is intended as the readable export baseline for crawler and low-capability delivery.